Answers are grounded in this paper and cite their sources.
Delgocitinib ointment was effective and well tolerated when applied to Japanese pediatric patients with AD for up to 56 weeks.
No takes yet. Share an insight, caveat, or question.
Nakagawa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: